Drug recall: DHEA/Pregnenol One 10.25 MG Cap
Class II FDA enforcement event 84527. Recall start date: . Status in the FDA record: Terminated. Termination date: .
Reason for recall, in the words of FDA
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Class II, in the words of FDA
a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
MPRX, Inc. dba Medical Park Pharmacy started this drug recall on 18 Dec 2019. The firm address in the FDA record is in Dallas, TX. FDA put the recall in Class II. FDA event 84527 has 18 product records. The first FDA enforcement report date is 5 Feb 2020. The record gives the status Terminated, with the termination date 13 Dec 2022.
It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.
FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .
Distribution
In the words of FDA.
TX
Recalling firm
MPRX, Inc. dba Medical Park Pharmacy, Dallas, TX.
Recalling firm: The firm that the FDA record names for a recall.
FDA records how the recall started: Voluntary: Firm initiated.
Products
18 product records in the event.
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| D-0803-2020 | DHEA/Pregnenol One 10.25 MG Cap | 1 bottle | Class II | Terminated | 5 Feb 2020 |
| D-0804-2020 | Finasteride/Biotin 1 mg/50 mcg | 1 bottle | Class II | Terminated | 5 Feb 2020 |
| D-0805-2020 | Lidocaine/Priloc/PE 15/5/0.25% 30 GM jars | 2 jars | Class II | Terminated | 5 Feb 2020 |
| D-0806-2020 | Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars | 12 jars | Class II | Terminated | 5 Feb 2020 |
| D-0807-2020 | Liothyronine (T3) 80 mcg SR cap | 5 bottles | Class II | Terminated | 5 Feb 2020 |
| D-0808-2020 | Liothyronine (T3) 92.5 MCG | 4 bottles | Class II | Terminated | 5 Feb 2020 |
| D-0809-2020 | Magic Bullet Supplement | 1 bottles | Class II | Terminated | 5 Feb 2020 |
| D-0810-2020 | Naltrexone 4.5 mg capsule | 2 bottles | Class II | Terminated | 5 Feb 2020 |
| D-0811-2020 | Progesterone 200 mg Troche | 1 bottle | Class II | Terminated | 5 Feb 2020 |
| D-0812-2020 | Progesterone 50 mg capsules | 1 bottle | Class II | Terminated | 5 Feb 2020 |
| D-0813-2020 | Progesterone E4M SR 100 mg capsules | 3 bottles | Class II | Terminated | 5 Feb 2020 |
| D-0814-2020 | Sildenafil 200 mg Troche (Clinic) | 1 bottle | Class II | Terminated | 5 Feb 2020 |
| D-0815-2020 | Sildenafil 80 mg capsules | 1 bottle | Class II | Terminated | 5 Feb 2020 |
| D-0816-2020 | Squaric Acid 0.1% Topical Solution (Clinic) 30 mL | 1 bottle | Class II | Terminated | 5 Feb 2020 |
| D-0817-2020 | T3/T4 SR 9 mcg/38 mcg capsule | 2 bottles | Class II | Terminated | 5 Feb 2020 |
| D-0818-2020 | Tadalafil 20 mg Troche | 9 bottles | Class II | Terminated | 5 Feb 2020 |
| D-0819-2020 | Tadalafil 6 mg Capsule | 7 bottles | Class II | Terminated | 5 Feb 2020 |
| D-0820-2020 | Testosterone Topical Cream 4% | 3 bottles | Class II | Terminated | 5 Feb 2020 |
openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.
Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.
Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.
Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.
Class II: The middle of the three FDA recall classes.
The event in context
- Drug events that started in 2019
- 362
- Share of these events in Class II
- 68%
- Product records in this event
- 18
- Events of the firm on the register
- 1
Official channels
- FDA enforcement report D-0803-2020The FDA record of the first product of this event.
- FDA: recalls, market withdrawals and safety alertsThe recall notices on the FDA site.
- FDA MedWatchThe FDA safety reporting program for drugs and medical devices.
Follow by RSS:Food, drug and device recallsFDA Class I recalls
Cite this page
Recall Register. FDA enforcement event 84527. https://recallregister.com/fda/ii/84527/. Source: openFDA enforcement reports. Data through .
Sources
- Source
- openFDA drug enforcement reports
- Licence
- CC0 1.0
- Export date
- 28 Sep 2026
- Newest FDA report date on the register
- 23 Sep 2026
FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.
Questions
- Where was the product distributed?
- The FDA record gives this distribution:
TX
- What quantity of product is in FDA event 84527?
- The event has 18 product records. The first record gives this quantity:
1 bottle
- How did the recall start?
- The FDA record says:
Voluntary: Firm initiated
- How many drug recalls of 2019 have the same class?
- 68% of the 362 drug events that started in 2019 are in Class II.